-
公开(公告)号：US20220025036A1
公开(公告)日：2022-01-27
申请号：US17415284
申请日：2019-12-18
Applicant: NOVARTIS AG
Inventor： Paola AIMONE , Connie WONG
IPC: C07K16/24 , A61P35/02 , A61K31/455 , A61K31/337 , C07K16/28 , A61K39/395
Abstract: Use of an IL-Iβ binding antibody or a functional fragment thereof, especially canakinumab or a functional fragment thereof, or gevokizumab or a functional fragment thereof, and biomarkers for the treatment of cancer with at least partial inflammatory basis, e.g., CML.
Search Results
1
records
(took 0.009 seconds)
筛选
AND
AND
过滤
NOT
NOT
Scan to Join
